AU2021900219A0 - Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use - Google Patents

Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use

Info

Publication number
AU2021900219A0
AU2021900219A0 AU2021900219A AU2021900219A AU2021900219A0 AU 2021900219 A0 AU2021900219 A0 AU 2021900219A0 AU 2021900219 A AU2021900219 A AU 2021900219A AU 2021900219 A AU2021900219 A AU 2021900219A AU 2021900219 A0 AU2021900219 A0 AU 2021900219A0
Authority
AU
Australia
Prior art keywords
mdma
enantiomers
manufacture
pharmaceutical preparations
novel method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021900219A
Inventor
Victor Chiruta
Robert Desmond Renshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Octavian and Desmond Pty Ltd
Original Assignee
Octavian and Desmond Pty Ltd
Filing date
Publication date
Application filed by Octavian and Desmond Pty Ltd filed Critical Octavian and Desmond Pty Ltd
Publication of AU2021900219A0 publication Critical patent/AU2021900219A0/en
Pending legal-status Critical Current

Links

AU2021900219A 2021-02-02 Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use Pending AU2021900219A0 (en)

Publications (1)

Publication Number Publication Date
AU2021900219A0 true AU2021900219A0 (en) 2021-02-18

Family

ID=

Similar Documents

Publication Publication Date Title
WO2023278843A3 (en) Solid forms of osanetant
AU2021235467A1 (en) Process for the synthesis of cannabidiol and intermediates thereof
EP4005561A4 (en) Nano-micelle preparation of icaritin and preparation method therefor and application thereof
AU2021900219A0 (en) Novel Method of Manufacture for MDMA, Different Intermediates, Enantiomers, Pharmaceutical Preparations, and Their Therapeutic Use
EP4122922A4 (en) Fused bicyclic derivative, preparation method therefor, and pharmaceutical use thereof
EP4076527A4 (en) Therapeutic combinations of drugs and methods of using them
EP4257117A4 (en) Sustained-release pharmaceutical composition of fulvestrant and method for preparing same
EP3912985A4 (en) Crystal forms of antidepressant drug sage-217 and preparation method therefor
AU2020904571A0 (en) Preparation of mdma, different enantiomers, polymorphs, intermediates, formulations and their use
AU2021337864A9 (en) Cellular composition for treatment of diseases, disorders or conditions and method of use
EP3946365A4 (en) Liposomal formulations, and methods of using and preparing thereof
HK40075920B (en) Pharmaceutical compositions, method of making and method of using thereof
HK40112039A (en) Crystal form of fused ring derivative, and preparation method therefor and use thereof
EP4430025A4 (en) Process and intermediates for preparation of isofetamid
EP4130008A4 (en) Novel derivative of beta-apopicropodophyllin and preparation method therefor
HK40111859A (en) Crystal form of lanifibranor, preparation method therefor, and use thereof
HK40113114A (en) Crystal form of lanifibranor, preparation method therefor, and use thereof
HK40109973A (en) Crystal form of tolebrutinib, preparation method therefor and use thereof
HK40111001A (en) Crystal form of tolebrutinib, preparation method therefor and use thereof
HK40108336A (en) 7-cyano-8-hydroxyquinoline derivative, preparation method therefor and medical use thereof
HK40094757A (en) Crystal form of tolebrutinib, preparation method therefor and use thereof
HK40110981A (en) Crystal form of tolebrutinib, preparation method therefor and use thereof
EP4159197A4 (en) Pharmaceutical preparation and preparation method therefor
HK40112305A (en) Pharmaceutical preparation, preparation method therefor and use thereof
AU2020900271A0 (en) Method of cannabinoid therapy